Sven Ante Lundberg

CIK: 0001682126

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)3 (6.4%)

Derivative conversions

Awards (A)13 (27.7%)

Compensation grants

Other (G, F, J, C, D, …)31 (66.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (4)

YARW

Yarrow Bioscience, Inc.

Director

QTTB

Q32 Bio Inc.

Director

MRUS

Merus N.V.

DirectorOfficer

VOR

Vor Biopharma Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (47 total)

QTTB
Q32 Bio Inc.
Jun 12, 2026
Award(A)
Stock Option (Right to Buy)
Direct
10.8K shares-
QTTB
Q32 Bio Inc.
Jun 12, 2026
Award(A)
Stock Option (Right to Buy)
Direct
9.8K shares-
QTTB
Q32 Bio Inc.
Jan 15, 2026
Award(A)
Stock Option (Right to Buy)
Direct
20.4K shares at avg. $2.75-
MRUS
Merus N.V.
Dec 12, 2025
Tender Offer(U)
Indirect
9.2K shares at avg. $97.00$892K
MRUS
Merus N.V.
Dec 12, 2025
Tender Offer(U)
Indirect
9.2K shares at avg. $97.00$892K
MRUS
Merus N.V.
Dec 12, 2025
Tender Offer(U)
Indirect
9.2K shares at avg. $97.00$892K
MRUS
Merus N.V.
Dec 12, 2025
Tender Offer(U)
Indirect
9.2K shares at avg. $97.00$892K
MRUS
Merus N.V.
Dec 12, 2025
Disposition(D)
Share Option (right to buy)
Direct
360K shares-
MRUS
Merus N.V.
Dec 12, 2025
Disposition(D)
Share Option (right to buy)
Direct
300K shares-
MRUS
Merus N.V.
Dec 12, 2025
Disposition(D)
Share Option (right to buy)
Direct
351.6K shares-
MRUS
Merus N.V.
Dec 12, 2025
Disposition(D)
Share Option (right to buy)
Direct
312.6K shares-
MRUS
Merus N.V.
Dec 12, 2025
Disposition(D)
Share Option (right to buy)
Direct
380K shares-
MRUS
Merus N.V.
Dec 12, 2025
Disposition(D)
Share Option (right to buy)
Direct
295K shares-
MRUS
Merus N.V.
Dec 12, 2025
Tender Offer(U)
Indirect
30.3K shares at avg. $97.00$2.9M
MRUS
Merus N.V.
Dec 12, 2025
Tender Offer(U)
Indirect
16.4K shares at avg. $97.00$1.6M
MRUS
Merus N.V.
Nov 25, 2025
Gift(G)
Indirect
2.5K shares-
MRUS
Merus N.V.
Nov 25, 2025
Gift(G)
Indirect
30.3K shares-
MRUS
Merus N.V.
Nov 25, 2025
Gift(G)
Indirect
14.2K shares-
MRUS
Merus N.V.
Nov 25, 2025
Gift(G)
Indirect
12.2K shares-
MRUS
Merus N.V.
Nov 25, 2025
Gift(G)
Indirect
52.4K shares-
MRUS
Merus N.V.
Nov 25, 2025
Gift(G)
Indirect
22.4K shares-
MRUS
Merus N.V.
Nov 25, 2025
Gift(G)
Indirect
24.2K shares-
MRUS
Merus N.V.
Nov 25, 2025
Gift(G)
Indirect
2.5K shares-
MRUS
Merus N.V.
Nov 25, 2025
Gift(G)
Indirect
2.5K shares-
MRUS
Merus N.V.
Nov 25, 2025
Gift(G)
Indirect
2.5K shares-

		Type	Shares	Price		Ownership
Jun 12, 2026	QTTB Q32 Bio Inc.	Award(A) Stock Option (Right to Buy)	10,826	-	-	Direct
Jun 12, 2026	QTTB Q32 Bio Inc.	Award(A) Stock Option (Right to Buy)	9,810	-	-	Direct
Jan 15, 2026	QTTB Q32 Bio Inc.	Award(A) Stock Option (Right to Buy)	20,363	$2.75	-	Direct
Dec 12, 2025	MRUS Merus N.V.	Tender Offer(U)	9,191	$97.00	$891,527	Indirect
Dec 12, 2025	MRUS Merus N.V.	Tender Offer(U)	9,191	$97.00	$891,527	Indirect
Dec 12, 2025	MRUS Merus N.V.	Tender Offer(U)	9,192	$97.00	$891,624	Indirect
Dec 12, 2025	MRUS Merus N.V.	Tender Offer(U)	9,192	$97.00	$891,624	Indirect
Dec 12, 2025	MRUS Merus N.V.	Disposition(D) Share Option (right to buy)	360,000	-	-	Direct
Dec 12, 2025	MRUS Merus N.V.	Disposition(D) Share Option (right to buy)	300,000	-	-	Direct
Dec 12, 2025	MRUS Merus N.V.	Disposition(D) Share Option (right to buy)	351,628	-	-	Direct
Dec 12, 2025	MRUS Merus N.V.	Disposition(D) Share Option (right to buy)	312,620	-	-	Direct
Dec 12, 2025	MRUS Merus N.V.	Disposition(D) Share Option (right to buy)	380,000	-	-	Direct
Dec 12, 2025	MRUS Merus N.V.	Disposition(D) Share Option (right to buy)	295,000	-	-	Direct
Dec 12, 2025	MRUS Merus N.V.	Tender Offer(U)	30,297	$97.00	$2,938,809	Indirect
Dec 12, 2025	MRUS Merus N.V.	Tender Offer(U)	16,372	$97.00	$1,588,084	Indirect
Nov 25, 2025	MRUS Merus N.V.	Gift(G)	2,539	-	-	Indirect
Nov 25, 2025	MRUS Merus N.V.	Gift(G)	30,297	-	-	Indirect
Nov 25, 2025	MRUS Merus N.V.	Gift(G)	14,198	-	-	Indirect
Nov 25, 2025	MRUS Merus N.V.	Gift(G)	12,215	-	-	Indirect
Nov 25, 2025	MRUS Merus N.V.	Gift(G)	52,369	-	-	Indirect
Nov 25, 2025	MRUS Merus N.V.	Gift(G)	22,449	-	-	Indirect
Nov 25, 2025	MRUS Merus N.V.	Gift(G)	24,229	-	-	Indirect
Nov 25, 2025	MRUS Merus N.V.	Gift(G)	2,538	-	-	Indirect
Nov 25, 2025	MRUS Merus N.V.	Gift(G)	2,539	-	-	Indirect
Nov 25, 2025	MRUS Merus N.V.	Gift(G)	2,539	-	-	Indirect

1-25 of 47 transactions

About Lundberg Sven Ante

Lundberg Sven Ante (SEC CIK 0001682126) files insider reports with the SEC as Director of Yarrow Bioscience, Inc. (YARW), Director of Q32 Bio Inc. (QTTB) and President, CEO & PEO of Merus N.V. (MRUS). Signal8 also holds filings tied to 1 other company.

Signal8 holds 14 ownership filings by Lundberg Sven Ante (1 Form 3, 13 Form 4), filed between Sep 27, 2024 and Jul 29, 2026. Those filings report 47 transactions, from Sep 25, 2024 to Jun 12, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Lundberg Sven Ante's filings is in WALTHAM, MA.

Recent filings by Lundberg Sven Ante

Jun 12, 2026: Grants or awards of QTTB derivative securities (2 lines, Form 4, code A).
Jan 15, 2026: Grant or award of QTTB derivative securities (Form 4, code A).
Dec 12, 2025: Tender of shares transactions of MRUS shares (4 lines, Form 4, code U).
Dec 12, 2025: Disposition to issuer transactions of MRUS derivative securities (6 lines, Form 4, code D).
Dec 12, 2025: Tender of shares transactions of MRUS shares (2 lines, Form 4, code U).

Other insiders filing for Yarrow Bioscience, Inc. (YARW)

Payton Lori, Chief Development Officer
Alford Rachael, Chief Operating Officer
Frey Rebecca, Chief Executive Officer
Ryder Steven, Chief Medical Officer
Zeronda Tyler, Chief Financial Officer
RTW Fund Group GP, LLC, 10% Owner

How to read Form 4 transaction codes